These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7723714)

  • 1. [TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy].
    Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A
    Med Klin (Munich); 1995 Mar; 90(3):134-7. PubMed ID: 7723714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease.
    Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A
    Exp Clin Endocrinol Diabetes; 1999; 107(1):21-8. PubMed ID: 10077351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.
    Kauffmann DJ; van Meurs JC; Mertens DA; Peperkamp E; Master C; Gerritsen ME
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):900-6. PubMed ID: 8125753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].
    Dujić M; Misailović K; Nikolić Lj; Ignjacev M
    Srp Arh Celok Lek; 1998; 126(11-12):457-60. PubMed ID: 9921019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
    Demircan N; Safran BG; Soylu M; Ozcan AA; Sizmaz S
    Eye (Lond); 2006 Dec; 20(12):1366-9. PubMed ID: 16284605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
    Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
    Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples.
    Adamiec-Mroczek J; Oficjalska-Młyńczak J; Misiuk-Hojło M
    Cytokine; 2010 Mar; 49(3):269-74. PubMed ID: 20015663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy.
    Gustavsson C; Agardh CD; Agardh E
    Acta Ophthalmol; 2013 Aug; 91(5):445-52. PubMed ID: 22520269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered retinal neovascularization in TNF receptor-deficient mice.
    Ilg RC; Davies MH; Powers MR
    Curr Eye Res; 2005 Nov; 30(11):1003-13. PubMed ID: 16282134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Freyberger H; Bröcker M; Yakut H; Hammer J; Effert R; Schifferdecker E; Schatz H; Derwahl M
    Exp Clin Endocrinol Diabetes; 2000; 108(2):106-9. PubMed ID: 10826517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.